![Cancer cells in an electron microscope scan. Courtesy of Pixabay](https://nocamels.com/wp-content/uploads/2018/06/cancer-cells-541954_1280-350x228.jpg)
Ayala Pharmaceuticals Secures $30M To Advance Treatment For Anti-Cancer Products
Ayala Pharmaceuticals, an Israeli clinical-stage company that develops medicines for cancers that are genetically defined, announced Tuesday it had closed a $30 million Series B funding round. The financing round was led by Swiss multinational pharmaceutical company Novartis, with participation from SBI JI Innovation Fund and existing investors Israel Biotech Fund, aMoon and Harel Insurance […]
May 30, 2019